NYVEPRIA

Pfizer Canada Ulc🇨🇦 Health Canada

Approval Id: 5e0067abd62dc2a2
Drug Approval Canada Name: NYVEPRIA
Product Name: NYVEPRIA
Status: Marketed
Status Date: 2021-01-18
Original Market Date: 2021-01-18
Din: 02506238
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 20:16.00
Atc Original: L03AA13 PEGFILGRASTIM
Atc Name: l 03 aa 13
Aig Number: 0149962001
Company Name: Pfizer Canada Ulc
Company Address: 17300 Trans-Canada Highway, Kirkland, Quebec, Canada, H9J 2M5
Company Detail Path: /organization/pfizer-canada-ulc

PEGFILGRASTIM

6 MG / 0.6 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

5e0067abd62dc2a2

Type

Standard